Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
Crossref DOI link: https://doi.org/10.1007/s40259-017-0223-8
Published Online: 2017-05-02
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yu, Xiaojie
Marshall, Michael J. E.
Cragg, Mark S.
Crispin, Max
Funding for this research was provided by:
Biotechnology and Biological Sciences Research Council
Against Breast Cancer
License valid from 2017-05-02